Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CRISPR Therapeutics

Request full access

Gene-based medicines for patients with serious diseases

SwitzerlandFounded 2013Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2016

CRISPR Therapeutics in its local ecosystem

Live from Dealroom

The CRISPR Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later14 investors entered at this stage

Employees mapped 344 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 21 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$112M

109 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See CRISPR Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.